nodes	percent_of_prediction	percent_of_DWPC	metapath
Nimodipine—CYP3A5—Clonidine—glaucoma	0.0699	0.228	CbGbCtD
Nimodipine—CYP3A4—Pilocarpine—glaucoma	0.0558	0.182	CbGbCtD
Nimodipine—CYP3A4—Brinzolamide—glaucoma	0.0438	0.143	CbGbCtD
Nimodipine—CYP3A4—Dorzolamide—glaucoma	0.0423	0.138	CbGbCtD
Nimodipine—CYP3A4—Methazolamide—glaucoma	0.0377	0.123	CbGbCtD
Nimodipine—CYP3A4—Acetazolamide—glaucoma	0.0302	0.0982	CbGbCtD
Nimodipine—CYP3A4—Clonidine—glaucoma	0.0273	0.0888	CbGbCtD
Nimodipine—NR3C2—ACE Inhibitor Pathway—MAS1—glaucoma	0.0166	0.111	CbGpPWpGaD
Nimodipine—NR3C2—ACE Inhibitor Pathway—ACE2—glaucoma	0.0126	0.0842	CbGpPWpGaD
Nimodipine—AHR—Circadian rythm related genes—ATOH7—glaucoma	0.00726	0.0485	CbGpPWpGaD
Nimodipine—AHR—Aryl Hydrocarbon Receptor Pathway—CYP1B1—glaucoma	0.00348	0.0233	CbGpPWpGaD
Nimodipine—AHR—Aryl Hydrocarbon Receptor—CYP1B1—glaucoma	0.00348	0.0233	CbGpPWpGaD
Nimodipine—AHR—Circadian rythm related genes—OPN4—glaucoma	0.00289	0.0193	CbGpPWpGaD
Nimodipine—NR3C2—ACE Inhibitor Pathway—NOS3—glaucoma	0.00277	0.0185	CbGpPWpGaD
Nimodipine—Amlodipine—CA1—glaucoma	0.00267	1	CrCbGaD
Nimodipine—CACNA1F—Alzheimers Disease—FAS—glaucoma	0.00233	0.0156	CbGpPWpGaD
Nimodipine—CACNB4—Transmission across Chemical Synapses—SLC6A13—glaucoma	0.00215	0.0144	CbGpPWpGaD
Nimodipine—CACNA1F—Alzheimers Disease—APOE—glaucoma	0.00214	0.0143	CbGpPWpGaD
Nimodipine—CACNA1F—Alzheimers Disease—BAD—glaucoma	0.002	0.0133	CbGpPWpGaD
Nimodipine—Cardiac disorder—Travoprost—glaucoma	0.00189	0.0035	CcSEcCtD
Nimodipine—Cardiac disorder—Brinzolamide—glaucoma	0.00187	0.00345	CcSEcCtD
Nimodipine—Hypersensitivity—Carteolol—glaucoma	0.00186	0.00345	CcSEcCtD
Nimodipine—Palpitations—Bimatoprost—glaucoma	0.00186	0.00344	CcSEcCtD
Nimodipine—Myalgia—Apraclonidine—glaucoma	0.00185	0.00342	CcSEcCtD
Nimodipine—Angiopathy—Travoprost—glaucoma	0.00185	0.00342	CcSEcCtD
Nimodipine—Immune system disorder—Travoprost—glaucoma	0.00184	0.0034	CcSEcCtD
Nimodipine—Angiopathy—Brinzolamide—glaucoma	0.00183	0.00338	CcSEcCtD
Nimodipine—Hypertension—Bimatoprost—glaucoma	0.00182	0.00336	CcSEcCtD
Nimodipine—Immune system disorder—Brinzolamide—glaucoma	0.00182	0.00336	CcSEcCtD
Nimodipine—Dizziness—Metipranolol—glaucoma	0.00181	0.00334	CcSEcCtD
Nimodipine—Flushing—Pilocarpine—glaucoma	0.00179	0.00332	CcSEcCtD
Nimodipine—Oedema—Apraclonidine—glaucoma	0.00177	0.00328	CcSEcCtD
Nimodipine—Hypersensitivity—Levobunolol—glaucoma	0.00176	0.00326	CcSEcCtD
Nimodipine—Pruritus—Diclofenamide—glaucoma	0.00176	0.00326	CcSEcCtD
Nimodipine—Cardiac failure congestive—Timolol—glaucoma	0.00175	0.00324	CcSEcCtD
Nimodipine—Cramp muscle—Betaxolol—glaucoma	0.00175	0.00324	CcSEcCtD
Nimodipine—Nervous system disorder—Apraclonidine—glaucoma	0.00174	0.00322	CcSEcCtD
Nimodipine—NR3C2—Nuclear Receptor transcription pathway—NR3C1—glaucoma	0.00173	0.0116	CbGpPWpGaD
Nimodipine—Rash—Metipranolol—glaucoma	0.00172	0.00319	CcSEcCtD
Nimodipine—Dermatitis—Metipranolol—glaucoma	0.00172	0.00318	CcSEcCtD
Nimodipine—CACNB3—Transmission across Chemical Synapses—SLC6A13—glaucoma	0.00172	0.0115	CbGpPWpGaD
Nimodipine—Depression—Clonidine—glaucoma	0.00172	0.00317	CcSEcCtD
Nimodipine—Alanine aminotransferase increased—Betaxolol—glaucoma	0.00171	0.00317	CcSEcCtD
Nimodipine—Headache—Metipranolol—glaucoma	0.00171	0.00317	CcSEcCtD
Nimodipine—Pruritus—Levobunolol—glaucoma	0.00169	0.00313	CcSEcCtD
Nimodipine—Nervous system disorder—Bimatoprost—glaucoma	0.00169	0.00312	CcSEcCtD
Nimodipine—Muscle spasms—Brinzolamide—glaucoma	0.00168	0.00311	CcSEcCtD
Nimodipine—Dizziness—Carteolol—glaucoma	0.00167	0.0031	CcSEcCtD
Nimodipine—CACNB1—Transmission across Chemical Synapses—SLC6A13—glaucoma	0.00167	0.0112	CbGpPWpGaD
Nimodipine—Diarrhoea—Carbachol—glaucoma	0.00166	0.00307	CcSEcCtD
Nimodipine—CACNB4—Neuronal System—SLC6A13—glaucoma	0.00165	0.011	CbGpPWpGaD
Nimodipine—Palpitations—Brimonidine—glaucoma	0.00165	0.00305	CcSEcCtD
Nimodipine—Dizziness—Diclofenamide—glaucoma	0.00165	0.00304	CcSEcCtD
Nimodipine—Diarrhoea—Levobunolol—glaucoma	0.00164	0.00303	CcSEcCtD
Nimodipine—Nausea—Metipranolol—glaucoma	0.00162	0.003	CcSEcCtD
Nimodipine—Muscle spasms—Pilocarpine—glaucoma	0.00162	0.00299	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Apraclonidine—glaucoma	0.00162	0.00299	CcSEcCtD
Nimodipine—Hypertension—Brimonidine—glaucoma	0.00161	0.00298	CcSEcCtD
Nimodipine—Dizziness—Carbachol—glaucoma	0.00161	0.00297	CcSEcCtD
Nimodipine—Myalgia—Brimonidine—glaucoma	0.00159	0.00294	CcSEcCtD
Nimodipine—Headache—Carteolol—glaucoma	0.00159	0.00293	CcSEcCtD
Nimodipine—Vomiting—Diclofenamide—glaucoma	0.00158	0.00293	CcSEcCtD
Nimodipine—Dizziness—Levobunolol—glaucoma	0.00158	0.00293	CcSEcCtD
Nimodipine—Dyspnoea—Apraclonidine—glaucoma	0.00158	0.00292	CcSEcCtD
Nimodipine—CACNB4—Transmission across Chemical Synapses—SLC6A1—glaucoma	0.00158	0.0105	CbGpPWpGaD
Nimodipine—Palpitations—Dorzolamide—glaucoma	0.00157	0.00291	CcSEcCtD
Nimodipine—Bradycardia—Clonidine—glaucoma	0.00157	0.00291	CcSEcCtD
Nimodipine—Pruritus—Latanoprost—glaucoma	0.00157	0.0029	CcSEcCtD
Nimodipine—Rash—Diclofenamide—glaucoma	0.00157	0.0029	CcSEcCtD
Nimodipine—AHR—Aryl Hydrocarbon Receptor—PTGS2—glaucoma	0.00157	0.0105	CbGpPWpGaD
Nimodipine—Diarrhoea—Methazolamide—glaucoma	0.00157	0.0029	CcSEcCtD
Nimodipine—Palpitations—Travoprost—glaucoma	0.00157	0.0029	CcSEcCtD
Nimodipine—Headache—Diclofenamide—glaucoma	0.00156	0.00288	CcSEcCtD
Nimodipine—Thrombocytopenia—Acetazolamide—glaucoma	0.00155	0.00287	CcSEcCtD
Nimodipine—Palpitations—Brinzolamide—glaucoma	0.00155	0.00286	CcSEcCtD
Nimodipine—Vomiting—Carbachol—glaucoma	0.00154	0.00286	CcSEcCtD
Nimodipine—Hepatitis—Clonidine—glaucoma	0.00154	0.00286	CcSEcCtD
Nimodipine—Hypertension—Dorzolamide—glaucoma	0.00154	0.00285	CcSEcCtD
Nimodipine—Dyspnoea—Bimatoprost—glaucoma	0.00153	0.00284	CcSEcCtD
Nimodipine—Rash—Carbachol—glaucoma	0.00153	0.00283	CcSEcCtD
Nimodipine—Hypertension—Travoprost—glaucoma	0.00153	0.00283	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Apraclonidine—glaucoma	0.00153	0.00283	CcSEcCtD
Nimodipine—Dermatitis—Carbachol—glaucoma	0.00153	0.00283	CcSEcCtD
Nimodipine—Oedema—Brimonidine—glaucoma	0.00152	0.00282	CcSEcCtD
Nimodipine—Headache—Carbachol—glaucoma	0.00152	0.00282	CcSEcCtD
Nimodipine—Hypertension—Brinzolamide—glaucoma	0.00151	0.0028	CcSEcCtD
Nimodipine—Myalgia—Travoprost—glaucoma	0.00151	0.00279	CcSEcCtD
Nimodipine—Nausea—Carteolol—glaucoma	0.0015	0.00278	CcSEcCtD
Nimodipine—Headache—Levobunolol—glaucoma	0.0015	0.00277	CcSEcCtD
Nimodipine—Depression—Betaxolol—glaucoma	0.00149	0.00276	CcSEcCtD
Nimodipine—Nervous system disorder—Brimonidine—glaucoma	0.00149	0.00276	CcSEcCtD
Nimodipine—Myalgia—Brinzolamide—glaucoma	0.00149	0.00276	CcSEcCtD
Nimodipine—Palpitations—Pilocarpine—glaucoma	0.00149	0.00275	CcSEcCtD
Nimodipine—AHR—Aryl Hydrocarbon Receptor—CDKN1B—glaucoma	0.00149	0.00993	CbGpPWpGaD
Nimodipine—AHR—Aryl Hydrocarbon Receptor Pathway—CDKN1B—glaucoma	0.00149	0.00993	CbGpPWpGaD
Nimodipine—Tachycardia—Brimonidine—glaucoma	0.00149	0.00275	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Bimatoprost—glaucoma	0.00148	0.00275	CcSEcCtD
Nimodipine—Nausea—Diclofenamide—glaucoma	0.00148	0.00273	CcSEcCtD
Nimodipine—Dizziness—Latanoprost—glaucoma	0.00147	0.00271	CcSEcCtD
Nimodipine—Liver function test abnormal—Timolol—glaucoma	0.00147	0.00271	CcSEcCtD
Nimodipine—Vomiting—Methazolamide—glaucoma	0.00146	0.0027	CcSEcCtD
Nimodipine—Oedema—Dorzolamide—glaucoma	0.00145	0.00269	CcSEcCtD
Nimodipine—Hypertension—Pilocarpine—glaucoma	0.00145	0.00269	CcSEcCtD
Nimodipine—Oedema—Travoprost—glaucoma	0.00145	0.00268	CcSEcCtD
Nimodipine—Rash—Methazolamide—glaucoma	0.00144	0.00267	CcSEcCtD
Nimodipine—Dermatitis—Methazolamide—glaucoma	0.00144	0.00267	CcSEcCtD
Nimodipine—Nausea—Carbachol—glaucoma	0.00144	0.00267	CcSEcCtD
Nimodipine—Headache—Methazolamide—glaucoma	0.00144	0.00266	CcSEcCtD
Nimodipine—Cardiac disorder—Clonidine—glaucoma	0.00143	0.00265	CcSEcCtD
Nimodipine—Myalgia—Pilocarpine—glaucoma	0.00143	0.00265	CcSEcCtD
Nimodipine—Hypotension—Brimonidine—glaucoma	0.00142	0.00263	CcSEcCtD
Nimodipine—Nausea—Levobunolol—glaucoma	0.00142	0.00263	CcSEcCtD
Nimodipine—Nervous system disorder—Travoprost—glaucoma	0.00142	0.00263	CcSEcCtD
Nimodipine—Tachycardia—Travoprost—glaucoma	0.00141	0.00261	CcSEcCtD
Nimodipine—Hyperhidrosis—Dorzolamide—glaucoma	0.00141	0.0026	CcSEcCtD
Nimodipine—Nervous system disorder—Brinzolamide—glaucoma	0.0014	0.00259	CcSEcCtD
Nimodipine—Angiopathy—Clonidine—glaucoma	0.0014	0.00259	CcSEcCtD
Nimodipine—Rash—Latanoprost—glaucoma	0.0014	0.00259	CcSEcCtD
Nimodipine—Dermatitis—Latanoprost—glaucoma	0.0014	0.00258	CcSEcCtD
Nimodipine—Tachycardia—Brinzolamide—glaucoma	0.00139	0.00258	CcSEcCtD
Nimodipine—Headache—Latanoprost—glaucoma	0.00139	0.00257	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Brimonidine—glaucoma	0.00139	0.00257	CcSEcCtD
Nimodipine—Oedema—Pilocarpine—glaucoma	0.00137	0.00254	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Acetazolamide—glaucoma	0.00137	0.00253	CcSEcCtD
Nimodipine—Bradycardia—Betaxolol—glaucoma	0.00137	0.00253	CcSEcCtD
Nimodipine—CACNB4—Axon guidance—NCK2—glaucoma	0.00137	0.00914	CbGpPWpGaD
Nimodipine—Nausea—Methazolamide—glaucoma	0.00136	0.00252	CcSEcCtD
Nimodipine—Hypotension—Dorzolamide—glaucoma	0.00136	0.00251	CcSEcCtD
Nimodipine—Dyspnoea—Brimonidine—glaucoma	0.00136	0.00251	CcSEcCtD
Nimodipine—Hypotension—Travoprost—glaucoma	0.00135	0.0025	CcSEcCtD
Nimodipine—Thrombocytopenia—Pilocarpine—glaucoma	0.00135	0.00249	CcSEcCtD
Nimodipine—Tachycardia—Pilocarpine—glaucoma	0.00134	0.00248	CcSEcCtD
Nimodipine—Hypotension—Brinzolamide—glaucoma	0.00134	0.00247	CcSEcCtD
Nimodipine—Hyperhidrosis—Pilocarpine—glaucoma	0.00133	0.00246	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Dorzolamide—glaucoma	0.00132	0.00245	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Travoprost—glaucoma	0.00132	0.00244	CcSEcCtD
Nimodipine—CACNB3—Neuronal System—SLC6A13—glaucoma	0.00132	0.00881	CbGpPWpGaD
Nimodipine—Gastrointestinal disorder—Brimonidine—glaucoma	0.00131	0.00243	CcSEcCtD
Nimodipine—Hypersensitivity—Apraclonidine—glaucoma	0.00131	0.00242	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Brinzolamide—glaucoma	0.0013	0.00241	CcSEcCtD
Nimodipine—Dyspnoea—Dorzolamide—glaucoma	0.0013	0.0024	CcSEcCtD
Nimodipine—Muscle spasms—Clonidine—glaucoma	0.00129	0.00239	CcSEcCtD
Nimodipine—Dyspnoea—Travoprost—glaucoma	0.00129	0.00239	CcSEcCtD
Nimodipine—Hypotension—Pilocarpine—glaucoma	0.00128	0.00237	CcSEcCtD
Nimodipine—CACNB1—Neuronal System—SLC6A13—glaucoma	0.00128	0.00857	CbGpPWpGaD
Nimodipine—Dyspnoea—Brinzolamide—glaucoma	0.00127	0.00236	CcSEcCtD
Nimodipine—CACNB3—Transmission across Chemical Synapses—SLC6A1—glaucoma	0.00126	0.00841	CbGpPWpGaD
Nimodipine—Pruritus—Apraclonidine—glaucoma	0.00125	0.00232	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Pilocarpine—glaucoma	0.00125	0.00232	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Travoprost—glaucoma	0.00125	0.00231	CcSEcCtD
Nimodipine—Flushing—Betaxolol—glaucoma	0.00125	0.00231	CcSEcCtD
Nimodipine—Cardiac disorder—Betaxolol—glaucoma	0.00125	0.00231	CcSEcCtD
Nimodipine—AHR—Aryl Hydrocarbon Receptor—VEGFA—glaucoma	0.00124	0.00826	CbGpPWpGaD
Nimodipine—Gastrointestinal disorder—Brinzolamide—glaucoma	0.00123	0.00228	CcSEcCtD
Nimodipine—CACNB1—Transmission across Chemical Synapses—SLC6A1—glaucoma	0.00122	0.00818	CbGpPWpGaD
Nimodipine—Dyspnoea—Pilocarpine—glaucoma	0.00122	0.00227	CcSEcCtD
Nimodipine—Depression—Timolol—glaucoma	0.00122	0.00226	CcSEcCtD
Nimodipine—Angiopathy—Betaxolol—glaucoma	0.00122	0.00226	CcSEcCtD
Nimodipine—Pruritus—Bimatoprost—glaucoma	0.00122	0.00225	CcSEcCtD
Nimodipine—Immune system disorder—Betaxolol—glaucoma	0.00121	0.00225	CcSEcCtD
Nimodipine—Diarrhoea—Apraclonidine—glaucoma	0.00121	0.00224	CcSEcCtD
Nimodipine—CACNB4—Neuronal System—SLC6A1—glaucoma	0.00121	0.00806	CbGpPWpGaD
Nimodipine—CYP3A5—Tamoxifen metabolism—CYP1B1—glaucoma	0.00119	0.00796	CbGpPWpGaD
Nimodipine—Palpitations—Clonidine—glaucoma	0.00119	0.0022	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Pilocarpine—glaucoma	0.00119	0.00219	CcSEcCtD
Nimodipine—Dizziness—Apraclonidine—glaucoma	0.00117	0.00217	CcSEcCtD
Nimodipine—Dizziness—Bimatoprost—glaucoma	0.00114	0.0021	CcSEcCtD
Nimodipine—Vomiting—Apraclonidine—glaucoma	0.00113	0.00209	CcSEcCtD
Nimodipine—Muscle spasms—Betaxolol—glaucoma	0.00113	0.00208	CcSEcCtD
Nimodipine—Hypersensitivity—Brimonidine—glaucoma	0.00112	0.00207	CcSEcCtD
Nimodipine—AHR—Adipogenesis—NR3C1—glaucoma	0.00112	0.00749	CbGpPWpGaD
Nimodipine—Bradycardia—Timolol—glaucoma	0.00112	0.00207	CcSEcCtD
Nimodipine—Dermatitis—Apraclonidine—glaucoma	0.00112	0.00207	CcSEcCtD
Nimodipine—Headache—Apraclonidine—glaucoma	0.00111	0.00206	CcSEcCtD
Nimodipine—Oedema—Clonidine—glaucoma	0.0011	0.00203	CcSEcCtD
Nimodipine—CACNB3—Axon guidance—NCK2—glaucoma	0.00109	0.00731	CbGpPWpGaD
Nimodipine—CYP3A4—Benzo(a)pyrene metabolism—CYP1B1—glaucoma	0.00109	0.00729	CbGpPWpGaD
Nimodipine—AHR—Adipogenesis—FAS—glaucoma	0.00109	0.00726	CbGpPWpGaD
Nimodipine—Diarrhoea—Acetazolamide—glaucoma	0.00109	0.00201	CcSEcCtD
Nimodipine—Rash—Bimatoprost—glaucoma	0.00108	0.00201	CcSEcCtD
Nimodipine—Dermatitis—Bimatoprost—glaucoma	0.00108	0.002	CcSEcCtD
Nimodipine—Anaemia—Betaxolol—glaucoma	0.00108	0.002	CcSEcCtD
Nimodipine—Pruritus—Brimonidine—glaucoma	0.00108	0.00199	CcSEcCtD
Nimodipine—Headache—Bimatoprost—glaucoma	0.00108	0.00199	CcSEcCtD
Nimodipine—Nervous system disorder—Clonidine—glaucoma	0.00108	0.00199	CcSEcCtD
Nimodipine—Thrombocytopenia—Clonidine—glaucoma	0.00107	0.00199	CcSEcCtD
Nimodipine—Hypersensitivity—Dorzolamide—glaucoma	0.00107	0.00198	CcSEcCtD
Nimodipine—Tachycardia—Clonidine—glaucoma	0.00107	0.00198	CcSEcCtD
Nimodipine—CYP3A4—Aflatoxin B1 metabolism—GSTM1—glaucoma	0.00107	0.00713	CbGpPWpGaD
Nimodipine—Hypersensitivity—Travoprost—glaucoma	0.00107	0.00197	CcSEcCtD
Nimodipine—CACNB1—Axon guidance—NCK2—glaucoma	0.00106	0.00711	CbGpPWpGaD
Nimodipine—Hyperhidrosis—Clonidine—glaucoma	0.00106	0.00196	CcSEcCtD
Nimodipine—AHR—Aryl Hydrocarbon Receptor—TNF—glaucoma	0.00106	0.00708	CbGpPWpGaD
Nimodipine—AHR—Aryl Hydrocarbon Receptor Pathway—TNF—glaucoma	0.00106	0.00708	CbGpPWpGaD
Nimodipine—Nausea—Apraclonidine—glaucoma	0.00105	0.00195	CcSEcCtD
Nimodipine—Hypersensitivity—Brinzolamide—glaucoma	0.00105	0.00195	CcSEcCtD
Nimodipine—CACNB2—Transmission across Chemical Synapses—SLC6A13—glaucoma	0.00105	0.00702	CbGpPWpGaD
Nimodipine—Dizziness—Acetazolamide—glaucoma	0.00105	0.00194	CcSEcCtD
Nimodipine—Palpitations—Betaxolol—glaucoma	0.00103	0.00191	CcSEcCtD
Nimodipine—AHR—Circadian rythm related genes—NGFR—glaucoma	0.00103	0.00688	CbGpPWpGaD
Nimodipine—Pruritus—Dorzolamide—glaucoma	0.00103	0.0019	CcSEcCtD
Nimodipine—Hypotension—Clonidine—glaucoma	0.00103	0.0019	CcSEcCtD
Nimodipine—Pruritus—Travoprost—glaucoma	0.00102	0.00189	CcSEcCtD
Nimodipine—Nausea—Bimatoprost—glaucoma	0.00102	0.00189	CcSEcCtD
Nimodipine—Cardiac disorder—Timolol—glaucoma	0.00102	0.00189	CcSEcCtD
Nimodipine—Hypersensitivity—Pilocarpine—glaucoma	0.00101	0.00187	CcSEcCtD
Nimodipine—Pruritus—Brinzolamide—glaucoma	0.00101	0.00187	CcSEcCtD
Nimodipine—Vomiting—Acetazolamide—glaucoma	0.00101	0.00187	CcSEcCtD
Nimodipine—Dizziness—Brimonidine—glaucoma	0.00101	0.00186	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Clonidine—glaucoma	0.000999	0.00185	CcSEcCtD
Nimodipine—Angiopathy—Timolol—glaucoma	0.000996	0.00184	CcSEcCtD
Nimodipine—Myalgia—Betaxolol—glaucoma	0.000996	0.00184	CcSEcCtD
Nimodipine—Diarrhoea—Dorzolamide—glaucoma	0.000995	0.00184	CcSEcCtD
Nimodipine—Headache—Acetazolamide—glaucoma	0.000994	0.00184	CcSEcCtD
Nimodipine—Immune system disorder—Timolol—glaucoma	0.000992	0.00184	CcSEcCtD
Nimodipine—CACNA1F—Alzheimers Disease—TNF—glaucoma	0.000991	0.00662	CbGpPWpGaD
Nimodipine—Diarrhoea—Travoprost—glaucoma	0.00099	0.00183	CcSEcCtD
Nimodipine—AHR—Circadian rythm related genes—NTRK1—glaucoma	0.000978	0.00654	CbGpPWpGaD
Nimodipine—Dyspnoea—Clonidine—glaucoma	0.000978	0.00181	CcSEcCtD
Nimodipine—Diarrhoea—Brinzolamide—glaucoma	0.000978	0.00181	CcSEcCtD
Nimodipine—CACNB4—Developmental Biology—NCK2—glaucoma	0.000977	0.00652	CbGpPWpGaD
Nimodipine—Pruritus—Pilocarpine—glaucoma	0.000972	0.0018	CcSEcCtD
Nimodipine—CACNB3—Neuronal System—SLC6A1—glaucoma	0.000965	0.00645	CbGpPWpGaD
Nimodipine—Dizziness—Dorzolamide—glaucoma	0.000961	0.00178	CcSEcCtD
Nimodipine—Rash—Brimonidine—glaucoma	0.00096	0.00178	CcSEcCtD
Nimodipine—Dermatitis—Brimonidine—glaucoma	0.000959	0.00177	CcSEcCtD
Nimodipine—Dizziness—Travoprost—glaucoma	0.000957	0.00177	CcSEcCtD
Nimodipine—Oedema—Betaxolol—glaucoma	0.000955	0.00177	CcSEcCtD
Nimodipine—Headache—Brimonidine—glaucoma	0.000954	0.00176	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Clonidine—glaucoma	0.000947	0.00175	CcSEcCtD
Nimodipine—Dizziness—Brinzolamide—glaucoma	0.000945	0.00175	CcSEcCtD
Nimodipine—Nausea—Acetazolamide—glaucoma	0.000942	0.00174	CcSEcCtD
Nimodipine—Diarrhoea—Pilocarpine—glaucoma	0.00094	0.00174	CcSEcCtD
Nimodipine—CACNB1—Neuronal System—SLC6A1—glaucoma	0.000939	0.00627	CbGpPWpGaD
Nimodipine—CACNA1S—Alzheimers Disease—FAS—glaucoma	0.000937	0.00626	CbGpPWpGaD
Nimodipine—Nervous system disorder—Betaxolol—glaucoma	0.000937	0.00173	CcSEcCtD
Nimodipine—Thrombocytopenia—Betaxolol—glaucoma	0.000935	0.00173	CcSEcCtD
Nimodipine—Tachycardia—Betaxolol—glaucoma	0.000932	0.00172	CcSEcCtD
Nimodipine—Vomiting—Dorzolamide—glaucoma	0.000924	0.00171	CcSEcCtD
Nimodipine—Hyperhidrosis—Betaxolol—glaucoma	0.000923	0.00171	CcSEcCtD
Nimodipine—Rash—Dorzolamide—glaucoma	0.000917	0.0017	CcSEcCtD
Nimodipine—Dermatitis—Dorzolamide—glaucoma	0.000916	0.00169	CcSEcCtD
Nimodipine—AHR—Integrated Breast Cancer Pathway—MMP1—glaucoma	0.000914	0.00611	CbGpPWpGaD
Nimodipine—Rash—Travoprost—glaucoma	0.000913	0.00169	CcSEcCtD
Nimodipine—Dermatitis—Travoprost—glaucoma	0.000912	0.00169	CcSEcCtD
Nimodipine—Headache—Dorzolamide—glaucoma	0.000911	0.00168	CcSEcCtD
Nimodipine—Vomiting—Brinzolamide—glaucoma	0.000909	0.00168	CcSEcCtD
Nimodipine—Dizziness—Pilocarpine—glaucoma	0.000908	0.00168	CcSEcCtD
Nimodipine—Headache—Travoprost—glaucoma	0.000907	0.00168	CcSEcCtD
Nimodipine—Nausea—Brimonidine—glaucoma	0.000904	0.00167	CcSEcCtD
Nimodipine—Rash—Brinzolamide—glaucoma	0.000901	0.00167	CcSEcCtD
Nimodipine—Dermatitis—Brinzolamide—glaucoma	0.0009	0.00167	CcSEcCtD
Nimodipine—Headache—Brinzolamide—glaucoma	0.000895	0.00166	CcSEcCtD
Nimodipine—Hypotension—Betaxolol—glaucoma	0.000892	0.00165	CcSEcCtD
Nimodipine—CACNA1F—Alzheimers Disease—TP53—glaucoma	0.000874	0.00584	CbGpPWpGaD
Nimodipine—Vomiting—Pilocarpine—glaucoma	0.000873	0.00162	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Betaxolol—glaucoma	0.00087	0.00161	CcSEcCtD
Nimodipine—CACNB3—Metabolism—NARFL—glaucoma	0.000866	0.00579	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—CA5A—glaucoma	0.000866	0.00579	CbGpPWpGaD
Nimodipine—Rash—Pilocarpine—glaucoma	0.000866	0.0016	CcSEcCtD
Nimodipine—Dermatitis—Pilocarpine—glaucoma	0.000865	0.0016	CcSEcCtD
Nimodipine—Nausea—Dorzolamide—glaucoma	0.000864	0.0016	CcSEcCtD
Nimodipine—Headache—Pilocarpine—glaucoma	0.000861	0.00159	CcSEcCtD
Nimodipine—CACNA1S—Alzheimers Disease—APOE—glaucoma	0.00086	0.00575	CbGpPWpGaD
Nimodipine—Nausea—Travoprost—glaucoma	0.00086	0.00159	CcSEcCtD
Nimodipine—Dyspnoea—Betaxolol—glaucoma	0.000851	0.00158	CcSEcCtD
Nimodipine—Nausea—Brinzolamide—glaucoma	0.000849	0.00157	CcSEcCtD
Nimodipine—Palpitations—Timolol—glaucoma	0.000845	0.00156	CcSEcCtD
Nimodipine—Hypertension—Timolol—glaucoma	0.000825	0.00153	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Betaxolol—glaucoma	0.000825	0.00153	CcSEcCtD
Nimodipine—AHR—Integrated Breast Cancer Pathway—BAD—glaucoma	0.000824	0.00551	CbGpPWpGaD
Nimodipine—Nausea—Pilocarpine—glaucoma	0.000816	0.00151	CcSEcCtD
Nimodipine—Myalgia—Timolol—glaucoma	0.000814	0.00151	CcSEcCtD
Nimodipine—Hypersensitivity—Clonidine—glaucoma	0.000808	0.0015	CcSEcCtD
Nimodipine—CACNB2—Neuronal System—SLC6A13—glaucoma	0.000805	0.00538	CbGpPWpGaD
Nimodipine—CACNA1S—Alzheimers Disease—BAD—glaucoma	0.000801	0.00535	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—NCK2—glaucoma	0.000781	0.00522	CbGpPWpGaD
Nimodipine—Oedema—Timolol—glaucoma	0.00078	0.00144	CcSEcCtD
Nimodipine—CACNA1S—Axon guidance—NCK2—glaucoma	0.000779	0.00521	CbGpPWpGaD
Nimodipine—Pruritus—Clonidine—glaucoma	0.000776	0.00144	CcSEcCtD
Nimodipine—CACNB2—Transmission across Chemical Synapses—SLC6A1—glaucoma	0.000769	0.00514	CbGpPWpGaD
Nimodipine—AHR—Circadian rythm related genes—FAS—glaucoma	0.000767	0.00512	CbGpPWpGaD
Nimodipine—Nervous system disorder—Timolol—glaucoma	0.000765	0.00142	CcSEcCtD
Nimodipine—CACNA1D—Alzheimers Disease—FAS—glaucoma	0.000761	0.00508	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—NCK2—glaucoma	0.000759	0.00507	CbGpPWpGaD
Nimodipine—Hyperhidrosis—Timolol—glaucoma	0.000754	0.0014	CcSEcCtD
Nimodipine—Diarrhoea—Clonidine—glaucoma	0.000751	0.00139	CcSEcCtD
Nimodipine—Hypotension—Timolol—glaucoma	0.000729	0.00135	CcSEcCtD
Nimodipine—Dizziness—Clonidine—glaucoma	0.000725	0.00134	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Timolol—glaucoma	0.000711	0.00132	CcSEcCtD
Nimodipine—Hypersensitivity—Betaxolol—glaucoma	0.000704	0.0013	CcSEcCtD
Nimodipine—CACNA1D—Alzheimers Disease—APOE—glaucoma	0.000698	0.00467	CbGpPWpGaD
Nimodipine—Vomiting—Clonidine—glaucoma	0.000698	0.00129	CcSEcCtD
Nimodipine—Dyspnoea—Timolol—glaucoma	0.000696	0.00129	CcSEcCtD
Nimodipine—Rash—Clonidine—glaucoma	0.000692	0.00128	CcSEcCtD
Nimodipine—Dermatitis—Clonidine—glaucoma	0.000691	0.00128	CcSEcCtD
Nimodipine—Headache—Clonidine—glaucoma	0.000687	0.00127	CcSEcCtD
Nimodipine—Pruritus—Betaxolol—glaucoma	0.000676	0.00125	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Timolol—glaucoma	0.000674	0.00125	CcSEcCtD
Nimodipine—CACNA1C—Alzheimers Disease—FAS—glaucoma	0.000668	0.00447	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—NCK2—glaucoma	0.000668	0.00446	CbGpPWpGaD
Nimodipine—Diarrhoea—Betaxolol—glaucoma	0.000653	0.00121	CcSEcCtD
Nimodipine—Nausea—Clonidine—glaucoma	0.000652	0.00121	CcSEcCtD
Nimodipine—CACNA1D—Alzheimers Disease—BAD—glaucoma	0.000651	0.00435	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—NCK2—glaucoma	0.000633	0.00423	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—PAX6—glaucoma	0.000633	0.00423	CbGpPWpGaD
Nimodipine—Dizziness—Betaxolol—glaucoma	0.000632	0.00117	CcSEcCtD
Nimodipine—CYP3A4—Estrogen metabolism—CYP1B1—glaucoma	0.000627	0.00419	CbGpPWpGaD
Nimodipine—CACNA1C—Alzheimers Disease—APOE—glaucoma	0.000614	0.0041	CbGpPWpGaD
Nimodipine—Vomiting—Betaxolol—glaucoma	0.000607	0.00112	CcSEcCtD
Nimodipine—Rash—Betaxolol—glaucoma	0.000602	0.00111	CcSEcCtD
Nimodipine—Dermatitis—Betaxolol—glaucoma	0.000602	0.00111	CcSEcCtD
Nimodipine—Headache—Betaxolol—glaucoma	0.000598	0.00111	CcSEcCtD
Nimodipine—CACNB2—Neuronal System—SLC6A1—glaucoma	0.000589	0.00394	CbGpPWpGaD
Nimodipine—Hypersensitivity—Timolol—glaucoma	0.000575	0.00106	CcSEcCtD
Nimodipine—CACNA1C—Alzheimers Disease—BAD—glaucoma	0.000572	0.00382	CbGpPWpGaD
Nimodipine—Nausea—Betaxolol—glaucoma	0.000567	0.00105	CcSEcCtD
Nimodipine—CACNA1S—Developmental Biology—NCK2—glaucoma	0.000556	0.00372	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—NCK2—glaucoma	0.000556	0.00372	CbGpPWpGaD
Nimodipine—CYP3A4—Tamoxifen metabolism—CYP1B1—glaucoma	0.000554	0.0037	CbGpPWpGaD
Nimodipine—Pruritus—Timolol—glaucoma	0.000552	0.00102	CcSEcCtD
Nimodipine—Diarrhoea—Timolol—glaucoma	0.000534	0.000988	CcSEcCtD
Nimodipine—CACNB2—Metabolism—NARFL—glaucoma	0.000529	0.00354	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—CA5A—glaucoma	0.000529	0.00354	CbGpPWpGaD
Nimodipine—CACNB3—Myometrial Relaxation and Contraction Pathways—NOS3—glaucoma	0.000527	0.00352	CbGpPWpGaD
Nimodipine—Dizziness—Timolol—glaucoma	0.000516	0.000955	CcSEcCtD
Nimodipine—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000515	0.00344	CbGpPWpGaD
Nimodipine—CYP3A5—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000508	0.00339	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—PAX6—glaucoma	0.000506	0.00338	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—CA5A—glaucoma	0.000501	0.00335	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—NARFL—glaucoma	0.000501	0.00335	CbGpPWpGaD
Nimodipine—CYP3A4—Estrogen metabolism—GSTM1—glaucoma	0.000501	0.00335	CbGpPWpGaD
Nimodipine—Vomiting—Timolol—glaucoma	0.000496	0.000918	CcSEcCtD
Nimodipine—Rash—Timolol—glaucoma	0.000492	0.00091	CcSEcCtD
Nimodipine—CACNB1—Developmental Biology—PAX6—glaucoma	0.000492	0.00329	CbGpPWpGaD
Nimodipine—Dermatitis—Timolol—glaucoma	0.000491	0.000909	CcSEcCtD
Nimodipine—Headache—Timolol—glaucoma	0.000489	0.000904	CcSEcCtD
Nimodipine—AHR—Integrated Breast Cancer Pathway—VEGFA—glaucoma	0.000477	0.00319	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—NCK2—glaucoma	0.000477	0.00319	CbGpPWpGaD
Nimodipine—Nausea—Timolol—glaucoma	0.000463	0.000857	CcSEcCtD
Nimodipine—AHR—Adipogenesis—TNF—glaucoma	0.000461	0.00308	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—NCK2—glaucoma	0.000452	0.00302	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—CA5A—glaucoma	0.00044	0.00294	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—NARFL—glaucoma	0.00044	0.00294	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—CA1—glaucoma	0.000423	0.00283	CbGpPWpGaD
Nimodipine—CYP3A5—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000417	0.00279	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—CTSA—glaucoma	0.00041	0.00274	CbGpPWpGaD
Nimodipine—CACNA1S—Alzheimers Disease—TNF—glaucoma	0.000398	0.00266	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—NCK2—glaucoma	0.000397	0.00265	CbGpPWpGaD
Nimodipine—CACNB4—Axon guidance—MMP2—glaucoma	0.00039	0.00261	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—CA2—glaucoma	0.000387	0.00259	CbGpPWpGaD
Nimodipine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000377	0.00252	CbGpPWpGaD
Nimodipine—AHR—Integrated Breast Cancer Pathway—TP53—glaucoma	0.000361	0.00241	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—PAX6—glaucoma	0.00036	0.00241	CbGpPWpGaD
Nimodipine—CACNA1S—Alzheimers Disease—TP53—glaucoma	0.000351	0.00234	CbGpPWpGaD
Nimodipine—NR3C2—Generic Transcription Pathway—CDKN2B—glaucoma	0.00034	0.00227	CbGpPWpGaD
Nimodipine—CACNA1D—Alzheimers Disease—TNF—glaucoma	0.000323	0.00216	CbGpPWpGaD
Nimodipine—CACNB3—Axon guidance—MMP2—glaucoma	0.000312	0.00209	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—PAX6—glaucoma	0.000309	0.00206	CbGpPWpGaD
Nimodipine—CACNB1—Axon guidance—MMP2—glaucoma	0.000304	0.00203	CbGpPWpGaD
Nimodipine—NR3C2—Generic Transcription Pathway—NR3C1—glaucoma	0.000299	0.002	CbGpPWpGaD
Nimodipine—CYP3A4—Tryptophan metabolism—CYP1B1—glaucoma	0.000296	0.00198	CbGpPWpGaD
Nimodipine—CACNB4—Axon guidance—MMP9—glaucoma	0.000293	0.00196	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—PAX6—glaucoma	0.000293	0.00195	CbGpPWpGaD
Nimodipine—AHR—Circadian rythm related genes—TP53—glaucoma	0.000287	0.00192	CbGpPWpGaD
Nimodipine—CACNA1D—Alzheimers Disease—TP53—glaucoma	0.000285	0.0019	CbGpPWpGaD
Nimodipine—CACNA1C—Alzheimers Disease—TNF—glaucoma	0.000284	0.0019	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—MMP2—glaucoma	0.000279	0.00186	CbGpPWpGaD
Nimodipine—CYP3A5—Biological oxidations—GSTT1—glaucoma	0.000278	0.00186	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—TXN—glaucoma	0.000273	0.00182	CbGpPWpGaD
Nimodipine—CACNB4—Axon guidance—VEGFA—glaucoma	0.000263	0.00176	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—CA1—glaucoma	0.000258	0.00173	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—PAX6—glaucoma	0.000257	0.00172	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—CTSA—glaucoma	0.00025	0.00167	CbGpPWpGaD
Nimodipine—CACNA1C—Alzheimers Disease—TP53—glaucoma	0.00025	0.00167	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—CA1—glaucoma	0.000245	0.00164	CbGpPWpGaD
Nimodipine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000239	0.0016	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—CTSA—glaucoma	0.000237	0.00158	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—CA2—glaucoma	0.000236	0.00158	CbGpPWpGaD
Nimodipine—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000236	0.00158	CbGpPWpGaD
Nimodipine—CACNB3—Axon guidance—MMP9—glaucoma	0.000235	0.00157	CbGpPWpGaD
Nimodipine—CACNB1—Axon guidance—MMP9—glaucoma	0.000228	0.00152	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—CA2—glaucoma	0.000224	0.0015	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—MMP2—glaucoma	0.000223	0.00149	CbGpPWpGaD
Nimodipine—CACNA1S—Axon guidance—MMP2—glaucoma	0.000222	0.00149	CbGpPWpGaD
Nimodipine—CYP3A5—Biological oxidations—CYP1B1—glaucoma	0.000222	0.00148	CbGpPWpGaD
Nimodipine—CYP3A5—Metapathway biotransformation—CYP1B1—glaucoma	0.000219	0.00146	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—MMP2—glaucoma	0.000217	0.00145	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—CA1—glaucoma	0.000215	0.00144	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—GSTT1—glaucoma	0.000211	0.00141	CbGpPWpGaD
Nimodipine—CACNB3—Axon guidance—VEGFA—glaucoma	0.000211	0.00141	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—MMP9—glaucoma	0.000209	0.0014	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—CTSA—glaucoma	0.000208	0.00139	CbGpPWpGaD
Nimodipine—CACNB1—Axon guidance—VEGFA—glaucoma	0.000205	0.00137	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—CA2—glaucoma	0.000197	0.00131	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—NARFL—glaucoma	0.000195	0.0013	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—CA5A—glaucoma	0.000195	0.0013	CbGpPWpGaD
Nimodipine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000194	0.0013	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—MMP2—glaucoma	0.000191	0.00127	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—VEGFA—glaucoma	0.000188	0.00126	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—MMP2—glaucoma	0.000181	0.00121	CbGpPWpGaD
Nimodipine—CYP3A5—Biological oxidations—GSTM1—glaucoma	0.000177	0.00118	CbGpPWpGaD
Nimodipine—CYP3A5—Metapathway biotransformation—GSTM1—glaucoma	0.000175	0.00117	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—ABCA1—glaucoma	0.000168	0.00113	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—CYP1B1—glaucoma	0.000168	0.00113	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—MMP9—glaucoma	0.000167	0.00112	CbGpPWpGaD
Nimodipine—CACNA1S—Axon guidance—MMP9—glaucoma	0.000167	0.00112	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—TXN—glaucoma	0.000167	0.00111	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—CDKN2B—glaucoma	0.000164	0.00109	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—MMP9—glaucoma	0.000163	0.00109	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—TNF—glaucoma	0.000161	0.00108	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—MMP2—glaucoma	0.000159	0.00106	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—MMP2—glaucoma	0.000159	0.00106	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—TXN—glaucoma	0.000158	0.00105	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—VEGFA—glaucoma	0.00015	0.001	CbGpPWpGaD
Nimodipine—CACNA1S—Axon guidance—VEGFA—glaucoma	0.00015	0.001	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—VEGFA—glaucoma	0.000146	0.000977	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—NR3C1—glaucoma	0.000144	0.000961	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—MMP9—glaucoma	0.000143	0.000957	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—TXN—glaucoma	0.000139	0.000926	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—MMP2—glaucoma	0.000136	0.000909	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—MMP9—glaucoma	0.000136	0.000907	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—GSTM1—glaucoma	0.000135	0.0009	CbGpPWpGaD
Nimodipine—CYP3A4—Biological oxidations—GSTT1—glaucoma	0.000129	0.000864	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—GSTT1—glaucoma	0.000129	0.000863	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—MMP2—glaucoma	0.000129	0.000861	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—TNF—glaucoma	0.000129	0.000861	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—VEGFA—glaucoma	0.000129	0.00086	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—TNF—glaucoma	0.000125	0.000837	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—GSTT1—glaucoma	0.000122	0.000817	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—VEGFA—glaucoma	0.000122	0.000814	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—MMP9—glaucoma	0.000119	0.000797	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—MMP9—glaucoma	0.000119	0.000797	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—MTHFR—glaucoma	0.000119	0.000795	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—MMP2—glaucoma	0.000113	0.000756	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—APOE—glaucoma	0.000111	0.00074	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—CAV1—glaucoma	0.00011	0.000733	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—GSTT1—glaucoma	0.000107	0.000718	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—VEGFA—glaucoma	0.000107	0.000716	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—VEGFA—glaucoma	0.000107	0.000715	CbGpPWpGaD
Nimodipine—CYP3A4—Biological oxidations—CYP1B1—glaucoma	0.000103	0.000688	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—ABCA1—glaucoma	0.000103	0.000687	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—CYP1B1—glaucoma	0.000103	0.000687	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—MMP9—glaucoma	0.000102	0.000683	CbGpPWpGaD
Nimodipine—CYP3A4—Metapathway biotransformation—CYP1B1—glaucoma	0.000102	0.000679	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—ABCA1—glaucoma	9.74e-05	0.000651	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—CYP1B1—glaucoma	9.74e-05	0.000651	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—MMP9—glaucoma	9.68e-05	0.000647	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—CA1—glaucoma	9.52e-05	0.000636	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—CTSA—glaucoma	9.22e-05	0.000616	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—VEGFA—glaucoma	9.18e-05	0.000614	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—TNF—glaucoma	9.18e-05	0.000613	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—CA5A—glaucoma	9.06e-05	0.000605	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—NARFL—glaucoma	9.06e-05	0.000605	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—CA2—glaucoma	8.71e-05	0.000582	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—VEGFA—glaucoma	8.7e-05	0.000581	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—ABCA1—glaucoma	8.56e-05	0.000572	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—CYP1B1—glaucoma	8.56e-05	0.000572	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—MMP9—glaucoma	8.51e-05	0.000569	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—NOS3—glaucoma	8.3e-05	0.000554	CbGpPWpGaD
Nimodipine—CYP3A4—Biological oxidations—GSTM1—glaucoma	8.24e-05	0.00055	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—GSTM1—glaucoma	8.22e-05	0.000549	CbGpPWpGaD
Nimodipine—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	8.12e-05	0.000543	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—TNF—glaucoma	7.87e-05	0.000526	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—GSTM1—glaucoma	7.79e-05	0.00052	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—VEGFA—glaucoma	7.64e-05	0.000511	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—PTGS2—glaucoma	7.59e-05	0.000507	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—TNF—glaucoma	7.45e-05	0.000498	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—MTHFR—glaucoma	7.27e-05	0.000486	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—MTHFR—glaucoma	6.88e-05	0.00046	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—GSTM1—glaucoma	6.84e-05	0.000457	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—APOE—glaucoma	6.77e-05	0.000452	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—CAV1—glaucoma	6.7e-05	0.000448	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—TNF—glaucoma	6.55e-05	0.000438	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—APOE—glaucoma	6.41e-05	0.000428	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—CAV1—glaucoma	6.35e-05	0.000424	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—TXN—glaucoma	6.13e-05	0.00041	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—MTHFR—glaucoma	6.05e-05	0.000404	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—APOE—glaucoma	5.63e-05	0.000376	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—CAV1—glaucoma	5.58e-05	0.000373	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—NOS3—glaucoma	5.07e-05	0.000339	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—NOS3—glaucoma	4.8e-05	0.000321	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—GSTT1—glaucoma	4.76e-05	0.000318	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—PTGS2—glaucoma	4.64e-05	0.00031	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—CA1—glaucoma	4.43e-05	0.000296	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—PTGS2—glaucoma	4.39e-05	0.000293	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—CTSA—glaucoma	4.29e-05	0.000286	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—NOS3—glaucoma	4.22e-05	0.000282	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—CA2—glaucoma	4.05e-05	0.00027	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—PTGS2—glaucoma	3.86e-05	0.000258	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—ABCA1—glaucoma	3.79e-05	0.000253	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—CYP1B1—glaucoma	3.79e-05	0.000253	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—GSTM1—glaucoma	3.03e-05	0.000202	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—TXN—glaucoma	2.85e-05	0.000191	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—MTHFR—glaucoma	2.68e-05	0.000179	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—APOE—glaucoma	2.49e-05	0.000167	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—CAV1—glaucoma	2.47e-05	0.000165	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—GSTT1—glaucoma	2.21e-05	0.000148	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—NOS3—glaucoma	1.87e-05	0.000125	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—ABCA1—glaucoma	1.76e-05	0.000118	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—CYP1B1—glaucoma	1.76e-05	0.000118	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PTGS2—glaucoma	1.71e-05	0.000114	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—GSTM1—glaucoma	1.41e-05	9.41e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—MTHFR—glaucoma	1.24e-05	8.32e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—APOE—glaucoma	1.16e-05	7.74e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—CAV1—glaucoma	1.15e-05	7.67e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—NOS3—glaucoma	8.68e-06	5.8e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PTGS2—glaucoma	7.94e-06	5.3e-05	CbGpPWpGaD
